Zealand Pharma A/S
CSE:ZEAL

Watchlist Manager
Zealand Pharma A/S Logo
Zealand Pharma A/S
CSE:ZEAL
Watchlist
Price: 406.4 DKK -5.53% Market Closed
Market Cap: 28.9B DKK
Have any thoughts about
Zealand Pharma A/S?
Write Note

Intrinsic Value

ZEAL's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one ZEAL stock under the Base Case scenario is 105.78 DKK. Compared to the current market price of 406.4 DKK, Zealand Pharma A/S is Overvalued by 74%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ZEAL Intrinsic Value
105.78 DKK
Overvaluation 74%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Zealand Pharma A/S

Valuation History Unavailable

Historical valuation for ZEAL cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Zealand Pharma A/S

Provide an overview of the primary business activities
of Zealand Pharma A/S.

What unique competitive advantages
does Zealand Pharma A/S hold over its rivals?

What risks and challenges
does Zealand Pharma A/S face in the near future?

Summarize the latest earnings call
of Zealand Pharma A/S.

What significant events have occurred
in Zealand Pharma A/S over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Zealand Pharma A/S.

Provide P/S
for Zealand Pharma A/S.

Provide P/E
for Zealand Pharma A/S.

Provide P/OCF
for Zealand Pharma A/S.

Provide P/FCFE
for Zealand Pharma A/S.

Provide P/B
for Zealand Pharma A/S.

Provide EV/S
for Zealand Pharma A/S.

Provide EV/GP
for Zealand Pharma A/S.

Provide EV/EBITDA
for Zealand Pharma A/S.

Provide EV/EBIT
for Zealand Pharma A/S.

Provide EV/OCF
for Zealand Pharma A/S.

Provide EV/FCFF
for Zealand Pharma A/S.

Provide EV/IC
for Zealand Pharma A/S.

Show me price targets
for Zealand Pharma A/S made by professional analysts.

What are the Revenue projections
for Zealand Pharma A/S?

How accurate were the past Revenue estimates
for Zealand Pharma A/S?

What are the Net Income projections
for Zealand Pharma A/S?

How accurate were the past Net Income estimates
for Zealand Pharma A/S?

What are the EPS projections
for Zealand Pharma A/S?

How accurate were the past EPS estimates
for Zealand Pharma A/S?

What are the EBIT projections
for Zealand Pharma A/S?

How accurate were the past EBIT estimates
for Zealand Pharma A/S?

Compare the revenue forecasts
for Zealand Pharma A/S with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Zealand Pharma A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Zealand Pharma A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Zealand Pharma A/S compared to its peers.

Compare the P/E ratios
of Zealand Pharma A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Zealand Pharma A/S with its peers.

Analyze the financial leverage
of Zealand Pharma A/S compared to its main competitors.

Show all profitability ratios
for Zealand Pharma A/S.

Provide ROE
for Zealand Pharma A/S.

Provide ROA
for Zealand Pharma A/S.

Provide ROIC
for Zealand Pharma A/S.

Provide ROCE
for Zealand Pharma A/S.

Provide Gross Margin
for Zealand Pharma A/S.

Provide Operating Margin
for Zealand Pharma A/S.

Provide Net Margin
for Zealand Pharma A/S.

Provide FCF Margin
for Zealand Pharma A/S.

Show all solvency ratios
for Zealand Pharma A/S.

Provide D/E Ratio
for Zealand Pharma A/S.

Provide D/A Ratio
for Zealand Pharma A/S.

Provide Interest Coverage Ratio
for Zealand Pharma A/S.

Provide Altman Z-Score Ratio
for Zealand Pharma A/S.

Provide Quick Ratio
for Zealand Pharma A/S.

Provide Current Ratio
for Zealand Pharma A/S.

Provide Cash Ratio
for Zealand Pharma A/S.

What is the historical Revenue growth
over the last 5 years for Zealand Pharma A/S?

What is the historical Net Income growth
over the last 5 years for Zealand Pharma A/S?

What is the current Free Cash Flow
of Zealand Pharma A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for Zealand Pharma A/S.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Zealand Pharma A/S

Current Assets 9B
Cash & Short-Term Investments 8.5B
Receivables 159.9m
Other Current Assets 253.7m
Non-Current Assets 164.1m
PP&E 129.6m
Intangibles 14.1m
Other Non-Current Assets 20.4m
Current Liabilities 356.9m
Accounts Payable 244.3m
Other Current Liabilities 112.5m
Non-Current Liabilities 456.9m
Long-Term Debt 378.2m
Other Non-Current Liabilities 78.7m
Efficiency

Free Cash Flow Analysis
Zealand Pharma A/S

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Zealand Pharma A/S

Revenue
55.7m DKK
Cost of Revenue
-3.7m DKK
Gross Profit
52m DKK
Operating Expenses
-1.5B DKK
Operating Income
-1.4B DKK
Other Expenses
216.3m DKK
Net Income
-1.2B DKK
Fundamental Scores

ZEAL Profitability Score
Profitability Due Diligence

Zealand Pharma A/S's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
ROE is Increasing
Negative 1-Year Revenue Growth
22/100
Profitability
Score

Zealand Pharma A/S's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

ZEAL Solvency Score
Solvency Due Diligence

Zealand Pharma A/S's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
75/100
Solvency
Score

Zealand Pharma A/S's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ZEAL Price Targets Summary
Zealand Pharma A/S

Wall Street analysts forecast ZEAL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZEAL is 972.65 DKK with a low forecast of 757.5 DKK and a high forecast of 1 176 DKK.

Lowest
Price Target
757.5 DKK
86% Upside
Average
Price Target
972.65 DKK
139% Upside
Highest
Price Target
1 176 DKK
189% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Zealand Pharma A/S
does not pay dividends
Shareholder Yield

Current shareholder yield for ZEAL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

ZEAL News

Other Videos
What is the Intrinsic Value of one ZEAL stock?

The intrinsic value of one ZEAL stock under the Base Case scenario is 105.78 DKK.

Is ZEAL stock undervalued or overvalued?

Compared to the current market price of 406.4 DKK, Zealand Pharma A/S is Overvalued by 74%.

Back to Top